Published in Infect Immun on November 01, 1999
Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med (2006) 8.63
Human hookworm infection in the 21st century. Adv Parasitol (2004) 2.43
Malaria and helminth interactions in humans: an epidemiological viewpoint. Ann Trop Med Parasitol (2006) 2.25
Impairment of protective immunity to blood-stage malaria by concurrent nematode infection. Infect Immun (2005) 1.47
Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis. Infect Immun (2004) 1.43
Impact of long-term treatment with ivermectin on the prevalence and intensity of soil-transmitted helminth infections. PLoS Negl Trop Dis (2008) 1.19
Impact of early life exposures to geohelminth infections on the development of vaccine immunity, allergic sensitization, and allergic inflammatory diseases in children living in tropical Ecuador: the ECUAVIDA birth cohort study. BMC Infect Dis (2011) 1.11
Children with retinopathy-negative cerebral malaria: a pathophysiologic puzzle. Pediatr Infect Dis J (2011) 1.08
Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10. Vaccine (2009) 0.93
Oesophagostomum dentatum extract modulates T cell-dependent immune responses to bystander antigens and prevents the development of allergy in mice. PLoS One (2013) 0.91
Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine. Infect Immun (2006) 0.89
Transmission intensity affects both antigen-specific and nonspecific T-cell proliferative responses in Loa loa infection. Infect Immun (2002) 0.80
Helminth infection alters IgE responses to allergens structurally related to parasite proteins. J Immunol (2014) 0.79
Nematode-derived proteins suppress proliferation and cytokine production of antigen-specific T cells via induction of cell death. PLoS One (2013) 0.78
Prolonged infection by Fonsecaea pedrosoi after antigenic co-stimulation at different sites in experimental murine chromoblastomycosis. Virulence (2010) 0.78
Nematode-induced interference with vaccination efficacy targets follicular T helper cell induction and is preserved after termination of infection. PLoS Negl Trop Dis (2014) 0.77
The influence of intestinal parasites on Plasmodium vivax-specific antibody responses to MSP-119 and AMA-1 in rural populations of the Brazilian Amazon. Malar J (2015) 0.76
Looking beyond the induction of Th2 responses to explain immunomodulation by helminths. Parasite Immunol (2015) 0.76
Human Helminths and Allergic Disease: The Hygiene Hypothesis and Beyond. Am J Trop Med Hyg (2016) 0.75
Soil transmitted helminth infections are not associated with compromised antibody responses to previously administered measles and tetanus vaccines among HIV-1 infected, ART naïve Kenyan adults. Parasite Epidemiol Control (2017) 0.75
Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol (1997) 4.22
A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med (1995) 4.21
Immunosuppression in children with malaria. Lancet (1972) 3.11
Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci U S A (1993) 2.65
Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis (1996) 2.42
Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen. J Immunol (1992) 2.14
Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J Infect Dis (1998) 1.76
Cell-mediated damage to helminths. Adv Parasitol (1984) 1.64
Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses. J Immunol (1993) 1.57
Tuberculin skin tests and B.C.G. vaccination in hyperendemic area of onchocerciasis. Lancet (1977) 1.55
Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. J Infect Dis (1991) 1.49
Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J Immunol (1992) 1.44
IL-4- and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. J Immunol (1993) 1.39
Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. J Immunol (1989) 1.39
Onchocerciasis in endemic and nonendemic populations: differences in clinical presentation and immunologic findings. J Infect Dis (1994) 1.34
Regulation of the immune response in lymphatic filariasis and onchocerciasis. Immunol Today (1991) 1.29
Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis. J Infect Dis (1994) 1.24
IgE and IgG subclass regulation by IL-4 and IFN-gamma in human helminth infections. Assessment by B cell precursor frequencies. J Immunol (1993) 1.09
Immunoregulation in human lymphatic filariasis: the role of interleukin 10. Parasite Immunol (1995) 1.09
The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection. Immunology (1997) 1.06
Use of monoclonal antibodies to quantify subclasses of human IgG. II. Enzyme immunoassay to define antigen specific (anti-filarial) IgG subclass antibodies. J Immunol Methods (1986) 1.04
Cell-mediated and humoral immune responses to BCG and rubella vaccinations and to recall antigens in onchocerciasis patients. Trop Med Parasitol (1989) 1.04
Naturally occurring blocking antibodies modulate immediate hypersensitivity responses in human filariasis. J Immunol (1981) 1.03
Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis. J Immunol (1990) 1.01
Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems. Bull World Health Organ (1997) 0.99
Guatemalan human onchocerciasis. II. Evidence for IgG3 involvement in acquired immunity to Onchocerca volvulus and identification of possible immune-associated antigens. J Immunol (1991) 0.95
The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand C (1986) 0.92
Cell-mediated and humoral immune response to tetanus vaccinations in onchocerciasis patients. Trop Med Parasitol (1989) 0.92
Successful control of onchocerciasis with community-based ivermectin distribution in the Rio Santiago focus in Ecuador. Trop Med Int Health (1997) 0.92
Tropical pulmonary eosinophilia: analysis of antifilarial antibody localized to the lung. J Infect Dis (1989) 0.88
Response to tetanus immunization in onchocerciasis patients. Ann Trop Med Parasitol (1983) 0.85
Isotype-specific characterization of antibody responses to Onchocerca volvulus in putatively immune individuals. Parasite Immunol (1995) 0.85
Onchocerciasis in Ecuador: infection in children in the Santiago Basin focus, province of Esmeraldas. Trans R Soc Trop Med Hyg (1990) 0.83
Immunogenicity of hepatitis B vaccine in patients infected with Schistosoma mansoni. Am J Trop Med Hyg (1987) 0.81
Antifilarial IgG4 antibodies in children from filaria-endemic areas correlate with duration of infection and are dissociated from antifilarial IgE antibodies. J Infect Dis (1994) 0.80
Circulating immune complexes and their possible relevance to other immunological parameters in Guatemalan onchocerciasis. Int Arch Allergy Appl Immunol (1983) 0.80
Immunological response to diphtheria/tetanus vaccine in Schistosomiasis mansoni patients. J Egypt Soc Parasitol (1992) 0.78
[Ultrastructural aspects of the degeneration of the dermal microfilaria O. volvulus under the effect of diethylcarbamazine in human onchocerciasis]. C R Seances Soc Biol Fil (1978) 0.77
The biological significance of specific antibody IgG subclass profiles. Monogr Allergy (1988) 0.77
CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol (1999) 3.32
In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J Clin Invest (1993) 2.84
Detection and quantitation of octopine in normal plant tissue and in crown gall tumors. Proc Natl Acad Sci U S A (1974) 2.67
Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science (2014) 2.20
Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun (2001) 2.09
Human infection with Ascaris lumbricoides is associated with a polarized cytokine response. J Infect Dis (2000) 2.05
Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest (1993) 2.00
An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science (1991) 1.86
Immunity to onchocerciasis: identification of a putatively immune population in a hyperendemic area of Ecuador. J Infect Dis (1994) 1.85
Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity (1997) 1.84
Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR. J Infect Dis (2000) 1.82
Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J Infect Dis (1998) 1.76
Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J Exp Med (1990) 1.71
Interferon-gamma in the management of infectious diseases. Ann Intern Med (1995) 1.68
Tropical medicine. BMJ (2000) 1.67
A rapid-format antibody card test for diagnosis of onchocerciasis. J Infect Dis (2000) 1.53
Immunologic responses to repeated ivermectin treatment in patients with onchocerciasis. J Infect Dis (1991) 1.52
High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis (1996) 1.51
Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. J Infect Dis (1991) 1.49
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors. J Clin Invest (1997) 1.46
Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations. J Infect Dis (1986) 1.45
Evaluation of a direct immunofluorescent antibody (DIFMA) test using Leishmania genus-specific monoclonal antibody in the routine diagnosis of cutaneous leishmaniasis. Rev Soc Bras Med Trop (1995) 1.43
Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+CD27- lymphocyte subpopulation. J Immunol (1995) 1.42
Absence of cellular responses to a putative autoantigen in onchocercal chorioretinopathy. Cellular autoimmunity in onchocercal chorioretinopathy. Invest Ophthalmol Vis Sci (1996) 1.42
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology (2000) 1.42
Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro. J Infect Dis (2000) 1.41
IL-4- and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. J Immunol (1993) 1.39
Tropical pulmonary eosinophilia. Annu Rev Med (1992) 1.38
Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals. J Infect Dis (1988) 1.36
Onchocerciasis in endemic and nonendemic populations: differences in clinical presentation and immunologic findings. J Infect Dis (1994) 1.34
Parallel regulation of IL-4 and IL-5 in human helminth infections. J Immunol (1992) 1.33
Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology (Berl) (1990) 1.32
Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun (2001) 1.32
Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. J Infect Dis (1995) 1.31
A polymerase chain reaction assay for detection of the parasite Wuchereria bancrofti in human blood samples. Am J Trop Med Hyg (1996) 1.30
Regulation of the immune response in lymphatic filariasis and onchocerciasis. Immunol Today (1991) 1.29
Parasite-specific anergy in human filariasis. Insights after analysis of parasite antigen-driven lymphokine production. J Clin Invest (1987) 1.28
Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies. J Immunol (1995) 1.28
Filarial parasite-specific T cell lines: induction of IgE synthesis. J Immunol (1985) 1.26
Immunologic tolerance in lymphatic filariasis. Diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic state. J Clin Invest (1992) 1.24
Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis. J Infect Dis (1994) 1.24
Eosinophilia in Southeast Asian refugees: evaluation at a referral center. J Infect Dis (1987) 1.22
Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol. Psychopharmacology (Berl) (1988) 1.19
Frequency analysis of IgE-secreting B lymphocytes in persons with normal or elevated serum IgE levels. J Immunol (1991) 1.19
Multicentre laboratory evaluation of Brugia Rapid dipstick test for detection of brugian filariasis. Trop Med Int Health (2003) 1.18
IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J Immunol (2000) 1.18
Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma. Proc Natl Acad Sci U S A (1989) 1.18
Type 2 cytokines and negative immune regulation in human infections. Curr Opin Immunol (1993) 1.13
Evidence for hybridization by multilocus enzyme electrophoresis and random amplified polymorphic DNA between Leishmania braziliensis and Leishmania panamensis/guyanensis in Ecuador. J Eukaryot Microbiol (1997) 1.12
Stage-specific induction of cytokines regulates the immune response in lymphatic filariasis. Exp Parasitol (1996) 1.10
Differentiation stimuli induce receptors for plasma fibronectin on the human myelomonocytic cell line HL-60. Blood (1984) 1.10
Intradermal hepatitis B virus vaccine: immunogenicity and side-effects in adults. Lancet (1984) 1.10
Serologic evidence of Cryptosporidium infection in US volunteers before and during Peace Corps service in Africa. Arch Intern Med (1989) 1.10
IgE and IgG subclass regulation by IL-4 and IFN-gamma in human helminth infections. Assessment by B cell precursor frequencies. J Immunol (1993) 1.09
Regulation of parasite antigen-driven immune responses by interleukin-10 (IL-10) and IL-12 in lymphatic filariasis. Infect Immun (1997) 1.09
Immunoregulation in human lymphatic filariasis: the role of interleukin 10. Parasite Immunol (1995) 1.09
Albendazole in human loiasis: results of a double-blind, placebo-controlled trial. J Infect Dis (1993) 1.08
The clinical and immunologic responses of normal human volunteers to low dose hookworm (Necator americanus) infection. Am J Trop Med Hyg (1987) 1.08
Current status of onchocerciasis in Colombia. Am J Trop Med Hyg (1998) 1.08
[Acute diarrhea associated with a Campylobacter and other pathogenic agents in Quito, Ecuador]. Bol Oficina Sanit Panam (1987) 1.08
Protective immunity in bancroftian filariasis. Selective recognition of a 43-kD larval stage antigen by infection-free individuals in an endemic area. J Clin Invest (1989) 1.07
An analysis of in vitro B cell immune responsiveness in human lymphatic filariasis. J Immunol (1987) 1.07
Circulating parasite antigen(s) in lymphatic filariasis: use of monoclonal antibodies to phosphocholine for immunodiagnosis. J Immunol (1987) 1.07
Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. Eur J Pharmacol (1990) 1.05
Elevated IL-10 mRNA expression and downregulation of Th1-type cytokines in microfilaraemic individuals with Wuchereria bancrofti infection. Parasite Immunol (1997) 1.05
Diminished monocyte function in microfilaremic patients with lymphatic filariasis and its relationship to altered lymphoproliferative responses. Infect Immun (2005) 1.05
Filarial antigens impair the function of human dendritic cells during differentiation. Infect Immun (2001) 1.05
Cytokine regulation of antigen-driven immunoglobulin production in filarial parasite infections in humans. J Clin Invest (1990) 1.05
Onchocerciasis in a nonendemic population: clinical and immunologic assessment before treatment and at the time of presumed cure. J Infect Dis (2000) 1.02
Genetic analysis of leishmania parasites in Ecuador: are Leishmania (Viannia) panamensis and Leishmania (V.) Guyanensis distinct taxa? Am J Trop Med Hyg (1999) 1.02
Regulation of IL-5 in onchocerciasis. A critical role for IL-2. J Immunol (1993) 1.01
IgE production in human helminth infection. Reciprocal interrelationship between IL-4 and IFN-gamma. J Immunol (1993) 0.99
Immunology of lymphatic filariasis. Parasite Immunol (2014) 0.99
Characterization and fractionation of tobacco leaf transfer RNA. Biochim Biophys Acta (1972) 0.99
Migration of a novel DQA1* allele (DQA1*0502) from African origin to North and South America. Hum Immunol (1995) 0.98
The pathogenesis of chorioretinal disease in onchocerciasis. Parasitol Today (1997) 0.97
Yaws in Ecuador: impact of control measures on the disease in the Province of Esmeraldas. Genitourin Med (1995) 0.97
Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the South Pacific. Am J Trop Med Hyg (2001) 0.97
Acute tropical pulmonary eosinophilia. Characterization of the lower respiratory tract inflammation and its response to therapy. J Clin Invest (1987) 0.97
CD45RB expression defines two interconvertible subsets of human CD4+ T cells with memory function. Eur J Immunol (1994) 0.96
Chagas disease in Ecuador: evidence for disease transmission in an Indigenous population in the Amazon region. Mem Inst Oswaldo Cruz (1998) 0.95
Immunoregulation in onchocerciasis. Functional and phenotypic abnormalities of lymphocyte subsets and changes with therapy. J Clin Invest (1991) 0.95
Cryptosporidiosis in Ecuadorian children with acute diarrhoea. J Trop Pediatr (1986) 0.95
Schistosoma mansoni: resistance to reinfection in the rat. Exp Parasitol (1977) 0.94
Early human infection with Onchocerca volvulus is associated with an enhanced parasite-specific cellular immune response. J Infect Dis (2001) 0.94